retired
Gastroenterology
Dr. Richard E. Sampliner, MD
|
|
Give Review
Richard E. Sampliner is an expert in the field of Gastroenterology. He attended Case Western Reserve University School of Medicine. He over the years received 6 awards: "Master endoscopist", "Mentors research scholar", "Fellow", "Governor, AZ", "Master" and "AGA distinguished clinician award". Richard Sampliner is a published doctor and has 42 publications published. The lastest was: 'Barrett's oesophagus length is established at the time of initial endoscopy and does not change over time: results from a large multicentre cohort.'
Publications
- Barrett's oesophagus length is established at the time of initial endoscopy and does not change over time: results from a large multicentre cohort.
- Persistence of Non-Dysplastic Barrett's Esophagus Identifies Patients at Lower Risk for Esophageal Adenocarcinoma-Results from a Large Multicenter Cohort.
- Association Between Length of Barrett's Esophagus and Risk of High-Grade Dysplasia or Adenocarcinoma in Patients Without Dysplasia.
- Overutilization of endoscopic surveillance in nondysplastic Barrett's esophagus: a multicenter study.
- Risk Factors for Progression of Low-Grade Dysplasia in Patients with Barrett's Esophagus.
- Durability of radiofrequency ablation in Barrett's esophagus with dysplasia.
- Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma.
- Medication usage and the risk of neoplasia in patients with Barrett's esophagus.
- Medical treatment of Barrett's esophagus: can it prevent cancer?
- Radiofrequency ablation in Barrett's esophagus with dysplasia.
- A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus.
- A surgical experience suggesting the threshold for endoscopic therapy.
- Expression of bile acid transporting proteins in Barrett's esophagus and esophageal adenocarcinoma.
- Response to Dr. Kelty et al.
- Finding the needle in the haystack: identifying the high-risk "premalignant" gastric lesion.
- The diagnostic accuracy of esophageal capsule endoscopy in patients with gastroesophageal reflux disease and Barrett's esophagus: a blinded, prospective study.
- Identification of Fn14/TWEAK receptor as a potential therapeutic target in esophageal adenocarcinoma.
- Five-year colon surveillance after screening colonoscopy.
- Activation of the interleukin-6/STAT3 antiapoptotic pathway in esophageal cells by bile acids and low pH: relevance to barrett's esophagus.
- Risk for cancer in Barrett's esophagus: medical versus surgical therapy.
- Endoscopic therapy for barrett's high-grade dysplasia: entering the therapeutic arena.
- Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus.
- A population prevalence of Barrett's esophagus--finally.
- Endoscopic antireflux procedures: a good wrap?
- Epidemiology, pathophysiology, and treatment of Barrett's esophagus: reducing mortality from esophageal adenocarcinoma.
- Apoptosis resistance in Barrett's esophagus: ex vivo bioassay of live stressed tissues.
- The better burn.
- Should patients with GERD be screened once at least for Barrett's epithelium? Pro: The need to screen GERD patients for Barrett's esophagus--a greater yield than surve...
- Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus.
- Is the length of newly diagnosed Barrett's esophagus decreasing? The experience of a VA Health Care System.
- Endoscopic ablative therapy for Barrett's esophagus: current status.
- Progression or regression of Barrett's esophagus--is it all in the eye of the beholder?
- Long-term endoscopic surveillance of Barrett's esophagus.
- Prevention of adenocarcinoma by reversing Barrett's esophagus with mucosal ablation.
- Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium.
- Multipolar electrocoagulation.
- Acid suppression therapy may not alter malignant progression in Barrett's metaplasia showing p53 protein accumulation.
- Relationship between rate of change in acid exposure along the esophagus and length of Barrett's epithelium.
- Impact of esophageal acid exposure on the endoscopic reversal of Barrett's esophagus.
- Barrett's Esophagus, a Complication of GERD.
- Appearance and prognosis of dysplasia in Barrett's esophagus.
Schools
Case Western Reserve University School of Medicine
University Hosps
Boston City Hospital
New England Med Center
Lemuel Shattuck Hospital
Doctors Specialties
- Gastroenterology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Assurant Health
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access
- Health Net PPO
- Health Net of Arizona HMO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Options PPO
- PacifiCare PPO
- United Healthcare
Awards
- Master endoscopist
- Mentors research scholar
- Fellow
- Governor, AZ
- Master
- AGA distinguished clinician award
Education
-
Boston University Medical Center -
Tufts Medical Center -
Case Western Reserve University - University Hospitals -
Case Western Reserve University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Ayaaz Ismail, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David R. Siegel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Debra J. Polson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steve Goldschmid, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sunitha M. Musuku, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Archita P. Desai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bhaskar Banerjee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bechara Mezher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rafael F. Perini, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rebecca A. Natrajan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fadi Deeb, MD
This Doctor is OpenDoctor Recommended.
|